FDA NDC Directory · JSON-LD · Markdown

Glyxambi

NDC 0597-0182 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Generic nameempagliflozin and linagliptin
Labeler / ManufacturerBoehringer Ingelheim Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA206073
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsEMPAGLIFLOZIN (10 mg/1)
LINAGLIPTIN (5 mg/1)
Marketing started20150130
Package count3

External sources

Source: openFDA. Public-domain (CC0).